Legal & General Group
DERM icon

Legal & General Group’s Journey Medical DERM Stock Holding History

Legal & General Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,801
Closed -$8.45K – 3432
2026
Q1 		$8.45K Buy
1,801
+454
+34% +$3.52K ﹤0.01% 3224
2025
Q4 		$10.4K Hold
1,347
– – ﹤0.01% 3238
2025
Q3 		$9.59K Hold
1,347
– – ﹤0.01% 3289
2025
Q2 		$9.65K Buy
+1,347
New +$9.31K ﹤0.01% 3299

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Legal & General Group's DERM Position: Q2 2026 in Review

Legal & General Group sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 1,801 shares — an estimated $8.45K sold.

Legal & General Group first reported a position in DERM in Q2 2025 and held it in 4 quarters. The position peaked at $10.4K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Legal & General Group reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 1,801 Journey Medical shares in Q2 2026, an estimated $8.45K.
  • Legal & General Group first reported a position in Journey Medical in Q2 2025 and held it in 4 quarters.
  • Legal & General Group's Journey Medical position peaked at $10.4K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.